What is Ipamorelin?

Pppp ipamorelin is a synthetic pentapeptide that acts as a ghrelin receptor agonist and growth hormone secretagogue (GHS). It was developed in 1998 through a large chemistry programme and was one of the first GHRP-receptor agonists with high selectivity for GH release. It is considered a potent and effective growth hormone secretagogue that does not interfere with other hormones like cortisol, which are involved in many important body processes. Initially, ipamorelin was investigated as a treatment for postoperative ileus, but further clinical study is required to fully understand its efficacy and safety profile.

When administered, ipamorelin sends a selective pulse through the hypothalamus and pituitary gland that triggers the natural production of Growth Hormone. The peptide supports muscle growth without impacting cartilage or bone deformation and is also known to promote restful sleep.

It has similar effects to other GHRPs, including promoting fat loss and increasing muscle mass. However, it is more clean and does not have the side effects that many other peptides can cause such as elevated hunger or elevated libido.

The recommended administration protocol for ipamorelin is 200mcg to 500mcg administered via subcutaneous injection daily. This is a safe, convenient and effective treatment for people who are looking to improve their overall health and well-being. It is a great option for those who want to improve their fitness level and look better, as it will help them build muscle mass and increase strength. Most patients who use ipamorelin to achieve this goal will continue with it for about 6-12 months.